Supernus Pharmaceuticals | SUPN - Trade Debtors


Supernus Pharmaceuticals reported $182.18M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Abbott USD 10.57B 171M Dec/2025
ANI Pharmaceuticals USD 255.43M 25.65M Mar/2026
Aurora Cannabis CAD 48.26M 1.53M Dec/2025
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Canopy Growth CAD 140.42M 113.56M Dec/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Corcept Therapeutics USD 39.07M 20.71M Mar/2026
Eisai JPY 227B 22.05B Mar/2026
Eli Lilly USD 21.18B 1.02B Mar/2026
Novo Nordisk DKK 106.26B 11.21B Mar/2026
Pacira USD 125.64M 1.57M Mar/2026
Perrigo USD 697.1M 84.3M Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026
United Therapeutics USD 312M 38.2M Mar/2026
Xeris Pharmaceuticals USD 51.05M 2.7M Dec/2025